Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer

Figure 4

Immunoinhibitors were positively correlated to the advanced stages in PC. TISIDB database analysis revealed the expression levels of TGFB1 (a), PVRL2 (b), CSF1R (c), TGFBR1 (d), VTCN1 (e), LGALS9 (f), IL10RB (g), KDR (h), and IDO1 (i) in stage I, II, III, and IV PC samples.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)